11 – 20 of 59
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Targeting IGF-IR improves neoadjuvant chemotherapy efficacy in breast cancers with low IGFBP7 expression
- Contribution to journal › Article
-
Mark
Genetic drivers and cellular selection of female mosaic X chromosome loss
- Contribution to journal › Article
-
Mark
Into the twilight zone – should ER-low breast cancer be treated as triple negative breast cancer?
- Contribution to journal › Debate/Note/Editorial
-
Mark
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
- Contribution to journal › Article
-
Mark
Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction
- Contribution to journal › Article
- 2023
-
Mark
Endogenous incretin levels and risk of first incident cancer: a prospective cohort study
- Contribution to journal › Article
-
Mark
Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
- Contribution to journal › Article
-
Mark
A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: Application to BRCA1 and BRCA2
- Contribution to journal › Article
-
Mark
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
- Contribution to journal › Article
-
Mark
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
- Contribution to journal › Article
